1. Home
  2. LWLG vs RCEL Comparison

LWLG vs RCEL Comparison

Compare LWLG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LWLG
  • RCEL
  • Stock Information
  • Founded
  • LWLG 1991
  • RCEL N/A
  • Country
  • LWLG United States
  • RCEL United States
  • Employees
  • LWLG N/A
  • RCEL N/A
  • Industry
  • LWLG Containers/Packaging
  • RCEL Medical/Dental Instruments
  • Sector
  • LWLG Industrials
  • RCEL Health Care
  • Exchange
  • LWLG Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • LWLG 560.5M
  • RCEL 107.8M
  • IPO Year
  • LWLG N/A
  • RCEL N/A
  • Fundamental
  • Price
  • LWLG $5.19
  • RCEL $3.75
  • Analyst Decision
  • LWLG
  • RCEL Buy
  • Analyst Count
  • LWLG 0
  • RCEL 5
  • Target Price
  • LWLG N/A
  • RCEL $11.80
  • AVG Volume (30 Days)
  • LWLG 1.6M
  • RCEL 263.1K
  • Earning Date
  • LWLG 11-07-2025
  • RCEL 11-06-2025
  • Dividend Yield
  • LWLG N/A
  • RCEL N/A
  • EPS Growth
  • LWLG N/A
  • RCEL N/A
  • EPS
  • LWLG N/A
  • RCEL N/A
  • Revenue
  • LWLG $94,355.00
  • RCEL $72,401,000.00
  • Revenue This Year
  • LWLG N/A
  • RCEL $19.96
  • Revenue Next Year
  • LWLG N/A
  • RCEL $33.43
  • P/E Ratio
  • LWLG N/A
  • RCEL N/A
  • Revenue Growth
  • LWLG 4.52
  • RCEL 20.59
  • 52 Week Low
  • LWLG $0.79
  • RCEL $3.35
  • 52 Week High
  • LWLG $6.26
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • LWLG 56.31
  • RCEL 38.44
  • Support Level
  • LWLG $4.68
  • RCEL $3.88
  • Resistance Level
  • LWLG $5.88
  • RCEL $3.91
  • Average True Range (ATR)
  • LWLG 0.47
  • RCEL 0.24
  • MACD
  • LWLG -0.01
  • RCEL -0.02
  • Stochastic Oscillator
  • LWLG 57.58
  • RCEL 41.90

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: